Literature DB >> 19521250

The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study.

Jessica Robinson-Papp1, Alejandra Gonzalez-Duarte, David M Simpson, Monica Rivera-Mindt, Susan Morgello.   

Abstract

BACKGROUND: In the pre-highly active antiretroviral therapy (HAART) era, distal sensory polyneuropathy (DSP) was associated with markers of advanced HIV infection and the use of neurotoxic antiretrovirals (ARVs). As HAART became widespread, and the AIDS epidemic shifted into minority populations, the risk factors for DSP became less clear. We explore the roles of ethnicity and ARV in the development of DSP in an HAART era cohort.
METHODS: Data from 336 HIV-positive adults were obtained from the Manhattan HIV Brain Bank. One hundred four participants had no DSP at entry visit; at least 1 follow-up visit; and a self-identified ethnicity of non-Hispanic white, Hispanic, or African American.
RESULTS: Fifty percent of participants developed DSP; of those, 67% were symptomatic. Participants who developed DSP were older (P = 0.02) and had higher CD4 counts (P = 0.001). ARV-DSP was more common in Hispanics (P = 0.02) and intravenous drug users (P = 0.02). There was a trend for higher pain scores in Hispanics with symptomatic DSP (P = 0.08).
CONCLUSIONS: This study suggests that there are ethnic disparities in the clinical manifestations of HIV-related neuropathies including pain and the susceptibility to ARV-DSP. Further studies of larger cohorts are indicated to explore the etiology of these differences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521250      PMCID: PMC2792902          DOI: 10.1097/QAI.0b013e3181adcefa

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  20 in total

1.  Ethnic similarities and differences in the chronic pain experience: a comparison of african american, Hispanic, and white patients.

Authors:  Robert R Edwards; Mario Moric; Brenda Husfeldt; Asokumar Buvanendran; Olga Ivankovich
Journal:  Pain Med       Date:  2005 Jan-Feb       Impact factor: 3.750

2.  Characterization of the Caucasian haplogroups present in the SWGDAM forensic mtDNA dataset for 1771 human control region sequences. Scientific Working Group on DNA Analysis Methods.

Authors:  Marc W Allard; Kevin Miller; Mark Wilson; Keith Monson; Bruce Budowle
Journal:  J Forensic Sci       Date:  2002-11       Impact factor: 1.832

3.  Characterization of human control region sequences of the African American SWGDAM forensic mtDNA data set.

Authors:  Marc W Allard; Deborah Polanskey; Kevin Miller; Mark R Wilson; Keith L Monson; Bruce Budowle
Journal:  Forensic Sci Int       Date:  2005-03-10       Impact factor: 2.395

4.  Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Authors:  Luda Diatchenko; Gary D Slade; Andrea G Nackley; Konakporn Bhalang; Asgeir Sigurdsson; Inna Belfer; David Goldman; Ke Xu; Svetlana A Shabalina; Dmitry Shagin; Mitchell B Max; Sergei S Makarov; William Maixner
Journal:  Hum Mol Genet       Date:  2004-11-10       Impact factor: 6.150

5.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Authors:  E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

6.  Ethnic differences in responses to multiple experimental pain stimuli.

Authors:  Claudia M Campbell; Robert R Edwards; Roger B Fillingim
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

7.  Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.

Authors:  H L McLeod; L Fang; X Luo; E P Scott; W E Evans
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

8.  2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.

Authors:  A R Berger; J C Arezzo; H H Schaumburg; G Skowron; T Merigan; S Bozzette; D Richman; W Soo
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.

Authors:  M Youle; M Osio
Journal:  HIV Med       Date:  2007-05       Impact factor: 3.180

Review 10.  Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.

Authors:  D M Simpson; M Tagliati
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-06-01
View more
  10 in total

Review 1.  Unique aspects of the care of HIV-positive Latino patients living in the United States.

Authors:  Joseph Metmowlee Garland; Adriana S Andrade; Kathleen R Page
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

2.  Substance abuse increases the risk of neuropathy in an HIV-infected cohort.

Authors:  Jessica Robinson-Papp; Benjamin B Gelman; Igor Grant; Elyse Singer; Gary Gensler; Susan Morgello
Journal:  Muscle Nerve       Date:  2012-04       Impact factor: 3.217

3.  Measures of small-fiber neuropathy in HIV infection.

Authors:  M S Boger; T Hulgan; D W Haas; V Mitchell; A G Smith; J R Singleton; A C Peltier
Journal:  Auton Neurosci       Date:  2012-04-28       Impact factor: 3.145

Review 4.  Neuromuscular diseases associated with HIV-1 infection.

Authors:  Jessica Robinson-Papp; David M Simpson
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

5.  Neurological complications in late-stage hospitalized patients with HIV disease.

Authors:  Rakendra Singh; Manjot Kaur; Deepak Arora
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

6.  The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in zimbabwe.

Authors:  Tinashe Mudzviti; Charles C Maponga; Star Khoza; Qing Ma; Gene D Morse
Journal:  AIDS Res Treat       Date:  2012-03-19

7.  Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].

Authors:  Angharad G Davis; Sean Wasserman; Mpumi Maxebengula; Cari Stek; Marise Bremer; Remy Daroowala; Saalikha Aziz; Rene Goliath; Stephani Stegmann; Sonya Koekemoer; Amanda Jackson; Louise Lai Sai; Yakub Kadernani; Thandi Sihoyiya; C Jason Liang; Lori Dodd; Paolo Denti; Thomas Crede; Jonathan Naude; Patryk Szymanski; Yakoob Vallie; Ismail Banderker; Shiraz Moosa; Peter Raubenheimer; Rachel P J Lai; John Joska; Sam Nightingale; Anna Dreyer; Gerda Wahl; Curtis Offiah; Isak Vorster; Sally Candy; Frances Robertson; Ernesta Meintjes; Gary Maartens; John Black; Graeme Meintjes; Robert J Wilkinson
Journal:  Wellcome Open Res       Date:  2021-06-01

Review 8.  Understanding the etiology and management of HIV-associated peripheral neuropathy.

Authors:  Kara Stavros; David M Simpson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.495

9.  Inadequate pain relief in ambulatory patients with human immunodeficiency virus disease in Port Harcourt.

Authors:  Longinus Ndubuisi Ebirim; Job Gogo Otokwala
Journal:  HIV AIDS (Auckl)       Date:  2013-08-13

10.  Normative values of quantitative sensory testing in Hispanic Latino population.

Authors:  Alejandra González-Duarte; Mónica Lem-Carrillo; Lorena Guerrero-Torres
Journal:  Brain Behav       Date:  2016-05-17       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.